首页 | 本学科首页   官方微博 | 高级检索  
     

肺癌肿瘤标志物的临床意义及研究进展
引用本文:任乂,赵金波. 肺癌肿瘤标志物的临床意义及研究进展[J]. 中国微生态学杂志, 2014, 0(4): 488-492
作者姓名:任乂  赵金波
作者单位:大连医科大学附属第二医院肿瘤内科,辽宁大连116027
摘    要:肺癌血清肿瘤标志物在肺癌的早期筛查、诊断、疗效评价、复发及预后预测等方面有重要的指导意义。本研究对目前临床常用的癌胚抗原(CEA)、神经元特异性烯醇化酶(NSE)、细胞角蛋白19片段抗原(CYFRA21—1)、鳞状细胞癌相关抗原(SCC—Ag)、乳酸脱氢酶(LDH)5种肺癌相关血清肿瘤标志物的临床意义及研究进展进行综述。

关 键 词:肺肿瘤  肿瘤标志物  诊断  治疗  进展

Advances and clinical significance of serum tumor markers in lung cancer
REN Yi,ZHAO Jin-bo. Advances and clinical significance of serum tumor markers in lung cancer[J]. Chinese Journal of Microecology, 2014, 0(4): 488-492
Authors:REN Yi  ZHAO Jin-bo
Affiliation:Department of Oncology, the Second Affiliated Hospital of Dalian Medical University, Dalian 116027, China
Abstract:Lung cancer shows a tendency of higher incidence and higher mortality in recent years, but the overall 5-year survival rate is less than 10% - 15%. Serum tumor markers have important significance in early screening, diagnosis, efficacy evaluation, recurrence and prognosis of lung cancer. In this paper, 5 most important lung cancer serum tumor markers were reviewed, including carcinoembryonic antigen ( CEA ) , neuron-specific enolase (NSE), cytokeratin fragment antigen 21-1 (CYFRA21-1) , squamous cell carcinoma related antigen (SCC-Ag) and lactate dehydrogenase (LDH).
Keywords:Lung neoplasms  Biological tumor marker  Diagnosis  Treatment  Progress
本文献已被 维普 等数据库收录!
点击此处可从《中国微生态学杂志》浏览原始摘要信息
点击此处可从《中国微生态学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号